Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ibio Inc IBIO

Healthcare Biotechnology
iBio, Inc. is a preclinical stage biotechnology company that leverages artificial intelligence (AI) for the development of precision antibodies. The Company develops biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard-to-target cancers and other diseases. Its StableHu... see more

Recent & Breaking News (NYSEAM:IBIO)

iBio Announces Leadership Succession, Appoints Thomas F. Isett Co-Chairman & CEO

GlobeNewswire March 12, 2020

iBio, Inc. Announces Withdrawal of Proxy Statement Proposal to Amend Its Certificate of Incorporation to Authorize a Possible Reverse Stock Split

GlobeNewswire March 2, 2020

iBio, Inc. Announces Postponement of Annual Meeting

GlobeNewswire February 6, 2020

iBio and CC-Pharming Initiate Joint Development of Coronavirus Vaccine

GlobeNewswire February 3, 2020

Researchers Say Flu Vaccines May Shrink Tumors and Aid in Treating Cancer

Livemoney January 22, 2020

iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance

GlobeNewswire January 16, 2020

iBio Initiates New Litigation Against Fraunhofer

GlobeNewswire January 6, 2020

EdgePoint announces collaboration with iBio CDMO to implement AI/Blockchain driven TrustPoint Vision Technology in its Texas cGMP facility

GlobeNewswire December 23, 2019

iBio Announces Collaboration with EdgePoint AI for Next Gen Quality in Biologics Manufacturing

GlobeNewswire December 23, 2019

iBio Reports Progress on its Bio-Better Rituximab Collaboration with CC-Pharming

GlobeNewswire December 16, 2019

iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan

GlobeNewswire December 13, 2019

iBio Introduces FastGlycaneering Development Service(TM) to Power Recombinant Protein Production

GlobeNewswire December 10, 2019

iBio Joins Manufacturing USA's Tissue Biofabrication Initiative

GlobeNewswire December 3, 2019

iBio to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference

GlobeNewswire December 2, 2019

iBio, Inc. Prices $5,000,000 Public Offering

GlobeNewswire October 25, 2019

iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan

GlobeNewswire October 22, 2019

iBio's Collaboration with South Africa's AzarGen Biotechnologies Advances to Next Stage

GlobeNewswire September 17, 2019

iBio and CC-Pharming Expand Business Collaboration in China

GlobeNewswire August 26, 2019

iBio Inks 3D Bioprinting Agreement

GlobeNewswire August 19, 2019

iBio Announces First Agreement for Fill-Finish Services

GlobeNewswire June 19, 2019